The Hormel Institute - University of Minnesota, Medical Research Center
Austin, Minnesota, 55912, United States
NCT Number: NCT06661590
Colorectal cancer survivors often face unique nutritional challenges and require support in their recovery and long0term health. While human experts have traditionally provided that support, there has been an increase in the use of Large Language Models (LLM) in medicine and in nutrition. The LLM offers a potential supplementary resource for generating personalized nutritional advice, specifically in personalized messaging. However, the efficacy and reliability of these AI-generated messages in comparison to human expert advice remain underexplored specific to this population.
This study aims to compare the nutrition-related content generated by popular LLMs-ChatGPT, Claude, Gemini, and Co-Pilot-against messages crafted by human experts. By evaluating the generated content in terms of readability, thematic relevance, medical relevance, perceived effectiveness, and implementation of participants' clinical practice, this research will provide insights into the strengths and limitations of using AI for nutritional guidance in colorectal cancer care.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Austin, Minnesota, 55912, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dieticians will evaluate nutritional messages created by LLM and Human Experts.
Time frame: 8 to 12 months
Description: The readability of AI-generated and human expert-generated nutrition messages will be measured using the Flesch-Kincaid Grade Level tool.
Unit of Measure: Grade level score (numerical score indicating reading difficulty level).
Measurement Tool: Flesch-Kincaid Grade Level formula. Scale values: The values vary from 0 to 18, where 18 represents the most difficult text.
Time frame: 8 to 12 months
Description: Thematic relevance of nutrition messages will be assessed by experts in nutrition using a thematic coding framework specifically designed for this study.
Unit of Measure: Percentage (%) of messages that align with pre-determined thematic codes relevant to colorectal cancer survivorship.
Measurement Tool: Thematic coding framework created by the research team. Scale values: The themes are capability (C), opportunity (O), and motivation (M) as three key factors capable of changing behavior (B).
Time frame: 8-12 months
Description: Medical relevance will be rated by specialists using a 0-5 relevance rating scale.
Unit of Measure: Mean relevance score (0-5). Measurement Tool: Dietitians/Participants review using a relevance rating scale.
Scale value: 1-5 (1- least, 5- most)
Time frame: 8-12 months
Description: Perceived effectiveness will be measured using a mean relevance score (1-5) administered to dietitians and participants.
Unit of Measure: Mean relevance score (1-5). Measurement Tool: Dietitians/Participants survey. Scale value: 1-5 (1- least, 5- most)
Time frame: 8-12 months
Description: Feasibility for clinical implementation will be rated by dietitians using a 1-5 feasibility scale.
Unit of Measure: Mean feasibility score. Measurement Tool: Dietitians/Participants survey. Scale value: 1-5 (1- least, 5- most)
University of Minnesota
Other
Comparative Analysis Between Artificial Intelligence vs. Human Generated Nutrition Messages for Colorectal Cancer Survivors
Acronym: NLM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03233737
No Disease State or Condition
Philadelphia, Pennsylvania, United States
View Trial Details